机读格式显示(MARC)
- 000 02057cam a2200313 i 4500
- 008 190623s2019 ne a b 001 0 eng d
- 020 __ |a 9789403506210 |q hardcover
- 020 __ |a 9403506210 |q hardcover
- 040 __ |a YDX |b eng |e rda |c YDX |d HVL |d Z |d OCLCF |d YDXIT
- 050 _4 |a KJC2636 |b .N44 2019
- 082 04 |a 346.404/8 |2 23
- 100 1_ |a Neethu, Rajam, |e author
- 245 10 |a Governing intellectual property rights within publicly funded biobanks / |c R. Neethu
- 260 __ |a Alphen aan den Rijn, the Netherlands : |b Kluwer Law International, |c [2019]
- 300 __ |a xxi, 330 pages : |b illustrations ; |c 25 cm
- 336 __ |a text |b txt |2 rdacontent
- 337 __ |a unmediated |b n |2 rdamedia
- 338 __ |a volume |b nc |2 rdacarrier
- 504 __ |a Includes bibliographical references (pages 309-320) and index
- 520 8_ |a Governing Intellectual Property Rights Within Publicly Funded Biobanks' addresses the implications that intellectual property rights (IPRs) have in the context of biobanks and how they need to be addressed in the governance of biobank-based research. The boom in biobanks and health databases as research infrastructures have evoked various legal and ethical debates. Since then numerous new developments have emerged such as digitalization, big-data research, and artificial intelligence that have important implications for biobank-based research and collaborations. This paradigm offers new legal challenges for commercial involvement, particularly within a publicly funded setting. In this innovative book, the author shows that securing maximum social benefit out of the knowledge emanating from the use of biobank resources lies in managing IP inputs and outputs effectively in keeping with the values that are core to such research
- 650 _0 |a Intellectual property |z Europe
- 650 _0 |a Biobanks |x Law and legislation |z Europe
- 650 _0 |a Medicine |x Research |x Law and legislation |z Europe
- 650 _0 |a Biotechnology |z Europe |v Patents